Cyril Y. Ramathal

The paper introduces INSIGHT, a deep learning framework that predicts drug response using multiomics data and drug molecular structure, outperforming existing methods and enabling biological interpretation.

This study uses deep learning to classify drug-naive and resistant cancer cells based on morphology, achieving high accuracy across multiple cancer types and drug classes.